Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'statins' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 286 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lorenzo Pradelli; Orietta Zaniolo
      Il valore clinico ed economico della lovastatina nella prevenzione cardiovascolare primaria

      Farmeconomia e percorsi terapeutici
    2. Dupuis, J
      Mechanisms of acute coronary syndromes and the potential role of statins

      ATHEROSCLEROSIS SUPPLEMENTS
    3. Avorn, J
      Unhealthy ageing: functional and socioeconomic impact

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    4. Buckley, BM
      Healthy ageing: ageing safely

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    5. Gaw, A
      Healthy ageing: addressing acute coronary syndrome?

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    6. Blauw, GJ; Bollen, ELEM; van Buchem, MA; Westendorp, RGJ
      Dementia at old age: a clinical end-point of atherosclerotic disease

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    7. Shepherd, J
      The role of the exogenous pathway in hypercholesterolaemia

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    8. Catapano, AL
      Ezetimibe: a selective inhibitor of cholesterol absorption

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    9. Stein, E
      Results of phase I/II clinical trials with ezetimibe, a novel selective cholesterol absorption inhibitor

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    10. Leitersdorf, E
      Cholesterol absorption inhibition: filling an unmet need in lipid-loweringmanagement

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    11. Bhatnagar, D; Mackness, MI; Durrington, PN
      Treatment of mixed hyperlipidaemia using a combination of omega-3 fatty acids and HMG CoA reductase inhibitor

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    12. Wiklund, O
      Treating lipids in cardiovascular disease: new directions

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    13. Kwak, B; Mulhaupt, F; Veillard, N; Pelli, G; Mach, F
      The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHCclass II expression in human vascular endothelial cells - Statins as a potential novel immunosuppressive agent

      SWISS MEDICAL WEEKLY
    14. Bonini, C; Cazzato, C; Cernia, E; Palocci, C; Soro, S; Viggiani, L
      Lipase enhanced catalytic efficiency in lactonisation reactions

      JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC
    15. Wierzbicki, AS
      Is a statin a statin?

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    16. Goppelt-Struebe, M; Hahn, A; Iwanciw, D; Rehm, M; Banas, B
      Regulation of connective tissue growth factor (ccn2*; ctgf) gene expression in human mesangial cells: modulation by HMG CoA reductase inhibitors (statins)

      JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
    17. Haq, IU; Ramsay, LE; Wallis, EJ; Isles, CG; Ritchie, LD; Jackson, PR
      Population implications of lipid lowering for prevention of coronary heartdisease: data from the 1995 Scottish Health Survey

      HEART
    18. Jones, AF; Walker, J; Jewkes, C; Game, FL; Bartlett, WA; Marshall, T; Bayly, GR
      Comparative accuracy of cardiovascular risk prediction methods in primary care patients

      HEART
    19. Doggrell, SA
      Statins in the 21st century: end of the simple story?

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    20. Whitfield, JF
      Statins: new drugs for treating osteoporosis?

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    21. Latini, R; Masson, S; Bertini, R; Maggioni, AP; Ghezzi, P; Calvillo, L
      Cardiac protection by pharmacological modulation of inflammation

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    22. Sheehy, N; Vaughan, CJ; Delanty, N
      Statins and neuroprotection

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    23. McDonald, R; Haycox, A; Walley, T
      The impact of health economics on healthcare delivery - The health economists' perspective

      PHARMACOECONOMICS
    24. Fendrick, AM; Smith, DG; Chernew, ME; Shah, SN
      A benefit-based copay for prescription drugs: Patient contribution based on total benefits, not drug acquisition cost

      AMERICAN JOURNAL OF MANAGED CARE
    25. Maciejko, JJ
      Clinical benefits from lowering cholesterol

      JOURNAL OF CLINICAL LIGAND ASSAY
    26. Diomede, L; Albani, D; Sottocorno, M; Donati, MB; Bianchi, M; Fruscella, P; Salmona, M
      In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    27. O'Neill, FH; Patel, DD; Knight, BL; Neuwirth, CKY; Bourbon, M; Soutar, AK; Taylor, GW; Thompson, GR; Naoumova, RP
      Determinants of variable response to statin treatment in patients with refractory familial hypercholesterolemia

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    28. Demer, LL
      Boning up (or down) on statins

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    29. Grand-Perret, T; Bouillot, A; Perrot, A; Commans, S; Walker, M; Issandou, M
      SCAP ligands are potent new lipid-lowering drugs

      NATURE MEDICINE
    30. Joyce, M; Kelly, CJ; Chen, G; Bouchier-Hayes, DJ
      Pravastatin attenuates lower torso ischaemia-reperfusion-induced lung injury by upregulating constitutive endothelial nitric oxide synthase

      EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
    31. Folzenlogen, D
      A case of atorvastatin combined toxic myopathy and inflammatory myositis

      JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
    32. Omar, MA; Wilson, JP; Cox, TS
      Rhabdomyolysis and HMG-CoA reductase inhibitors

      ANNALS OF PHARMACOTHERAPY
    33. Shek, A; Ferrill, MJ
      Statin-fibrate combination therapy

      ANNALS OF PHARMACOTHERAPY
    34. Metz, CA; Lucas, KH
      Alternate-day dosing of HMG-CoA reductase inhibitors for cholesterol reduction

      ANNALS OF PHARMACOTHERAPY
    35. Lee, AJ; Maddix, DS
      Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin

      ANNALS OF PHARMACOTHERAPY
    36. Papadakis, JA; Milionis, HJ; Press, M; Mikhailidis, DP
      Treating dyslipidaemia in non-insulin-dependent diabetes mellitus - a special reference to statins

      JOURNAL OF DIABETES AND ITS COMPLICATIONS
    37. Penson, MG; Fricker, FJ; Thompson, JR; Harker, K; Williams, BJ; Kahler, DA; Schowengerdt, KO
      Safety and efficacy of pravastatin therapy for the prevention of hyperlipidemia in pediatric and adolescent cardiac transplant recipients

      JOURNAL OF HEART AND LUNG TRANSPLANTATION
    38. Gaist, D; Rodriguez, LAG; Huerta, C; Hallas, J; Sindrup, SH
      Lipid-lowering drugs and risk of myopathy: A population based follow-up study

      EPIDEMIOLOGY
    39. Piorunska-Stolzmann, M; Piorunska-Mikolajczak, A
      The influence of simvastatin on lipase and cholesterol esterase activity in the serum of men with coronary heart disease

      PHARMACOLOGICAL RESEARCH
    40. Gil-Nunez, AC; Villanueva, JA
      Advantages of lipid-lowering therapy in cerebral ischemia: Role of HMG-CoAreductase inhibitors

      CEREBROVASCULAR DISEASES
    41. Christenson, JT
      Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization

      CARDIOVASCULAR SURGERY
    42. Lievre, M; Menard, J; Bruckert, E; Cogneau, J; Delahaye, F; Giral, P; Leitersdorf, E; Luc, G; Masana, L; Moulin, P; Passa, P; Pouchain, D; Siest, G
      Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility

      BRITISH MEDICAL JOURNAL
    43. Yasojima, K; McGeer, EG; McGeer, PL
      3-Hydroxy-3-methylglutaryl-coenzyme A reductase mRNA in Alzheimer and control brain

      NEUROREPORT
    44. Corti, R; Badimon, JJ
      Value or desirability of hemorheological-hemostatic parameter changes as endpoints in blood lipid-regulating trials

      CURRENT OPINION IN LIPIDOLOGY
    45. Evans, M; Owen, P; Ogunko, A
      Therapy and clinical trials

      CURRENT OPINION IN LIPIDOLOGY
    46. Steinmetz, A; Fenselau, S; Schrezenmeir, J
      Treatment of dyslipoproteinemia in the metabolic syndrome

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    47. Harder, S; Mohr, O; Klepzig, H
      Lipid-lowering treatment in coronary artery disease: a survey in an ambulatory outpatient clinic

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    48. Schubert, I; Koster, I; Ihle, P; von Ferber, L
      Development of indicators for assessing the quality of prescribing of lipid-lowering drugs: data from the pharmacotherapeutic quality circles in Hesse, Germany

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    49. Rise, P; Pazzucconi, F; Sirtori, CR; Galli, C
      Statins enhance arachidonic acid synthesis in hypercholesterolemic patients

      NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
    50. Nordoy, A; Hansen, JB; Brox, J; Svensson, B
      Effects of atorvastatin and omega-3 fatty acids on LDL subfractions and postprandial hyperlipemia in patients with combined hyperlipemia

      NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
    51. Insull, W; Kafonek, S; Goldner, D
      Translated Paper: Comparison of efficacy and safety of atorvastatin (10 mg) and simvastatin (10 mg) at six weeks.

      PERFUSION
    52. Massy, ZA; Guijarro, C
      Statins: effects beyond cholesterol lowering

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    53. Reid, F; Fossland, B; Flapan, AD; Duckelmann, CC; Hudson, SA
      Evaluation of the implementation of a local treatment guideline in secondary prevention post-myocardial infarction

      PHARMACY WORLD & SCIENCE
    54. Hagenaars, T; Gussenhoven, EJ; Poldermans, D; van Urk, H; van der Lugt, A
      Rationale and design for the SARIS trial; Effect of statin on atherosclerosis and vascular remodeling assessed with intravascular sonography

      CARDIOVASCULAR DRUGS AND THERAPY
    55. Dechend, R; Fiebler, A; Lindschau, C; Bischoff, H; Muller, D; Park, JK; Dietz, R; Haller, H; Luft, FC
      Modulating angiotensin II-induced inflammation by HMG Co-A reductase inhibition

      AMERICAN JOURNAL OF HYPERTENSION
    56. Leibovitz, E; Hazanov, N; Zimlichman, R; Shargorodsky, M; Gavish, D
      Treatment with atorvastatin improves small artery compliance in patients with severe hypercholesterolemia

      AMERICAN JOURNAL OF HYPERTENSION
    57. Rudling, M; Angelin, B
      Growth hormone reduces plasma cholesterol in LDL receptor-deficient mice

      FASEB JOURNAL
    58. Sata, M; Nishimatsu, H; Suzuki, E; Sugiura, S; Yoshizumi, M; Ouchi, Y; Hirata, Y; Nagai, R
      Endothelial nitric oxide synthase is essential for the HMG-CoA reductase inhibitor cerivastatin to promote collateral growth in response to ischemia

      FASEB JOURNAL
    59. Thompson, RB
      Foundations for blockbuster drugs in federally sponsored research

      FASEB JOURNAL
    60. Grootendorst, PV; Dolovich, LR; O'Brien, BJ; Holbrook, AM; Levy, AR
      Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs

      CANADIAN MEDICAL ASSOCIATION JOURNAL
    61. Wang, EJ; Casciano, CN; Clement, RP; Johnson, WW
      HMG-CoA reductase inhibitors (statins) characterized as direct inhibitors of P-glycoprotein

      PHARMACEUTICAL RESEARCH
    62. Stanislaus, R; Singh, AK; Singh, I
      Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis

      JOURNAL OF NEUROSCIENCE RESEARCH
    63. Horlitz, M; Sigwart, U; Niebauer, J
      Statins do not prevent restenosis after coronary angioplasty: Where to go from here?

      HERZ
    64. Kolovou, G
      The treatment of coronary heart disease: An update - Part 3: Statins beyond cholesterol lowering

      CURRENT MEDICAL RESEARCH AND OPINION
    65. Mikhailidis, DP
      The treatment of coronary heart disease: An update - Part 5: Selected comments and questions

      CURRENT MEDICAL RESEARCH AND OPINION
    66. Wierzbicki, AS
      Synthetic statins: More data on newer lipid-lowering agents

      CURRENT MEDICAL RESEARCH AND OPINION
    67. Lablanche, JM
      Achieving LDL-C target levels: The role of statins

      CURRENT MEDICAL RESEARCH AND OPINION
    68. Wienbergen, H; Schiele, R; Gitt, AK; Schneider, S; Heer, T; Gohlke, H; Gottwik, M; Thiele, M; Thiele, R; Keysser, M; Horsch, A; Weizel, A; Senges, J
      Actual use of statins at hospital discharge after acute myocardial infarction

      ZEITSCHRIFT FUR KARDIOLOGIE
    69. Wassmann, S; Laufs, U; Baumer, AT; Muller, K; Ahlbory, K; Linz, W; Itter, G; Rosen, R; Bohm, M; Nickenig, G
      HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species

      HYPERTENSION
    70. Coelho, OR; De Luca, IMS; Tanus-Santos, JE; Cittadino, M; Sampaio, RC; Coelho, OR; Hyslop, S; Moreno, H
      Pravastatin reduces myocardial lesions induced by acute inhibition of nitric oxide biosynthesis in normocholesterolemic rats

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    71. Hartmann, T
      Cholesterol, A beta and Alzheimer's disease

      TRENDS IN NEUROSCIENCES
    72. Isaacsohn, J; Insull, W; Stein, E; Kwiterovich, P; Ma, P; Brazg, R; Dujovne, CA; Shan, M; Shugrue-Crowley, E; Ripa, S; Tota, R
      Long-term efficacy and safety of cerivastatin 0.8 mg in patients with primary hypercholesterolemia

      CLINICAL CARDIOLOGY
    73. Waters, DD
      What do the statin trials tell us?

      CLINICAL CARDIOLOGY
    74. Olsson, AG
      A new statin: A new standard

      CLINICAL CARDIOLOGY
    75. Auer, J; Berent, R; Eber, B
      Lessons learned from statin trials

      CLINICAL CARDIOLOGY
    76. Lopez, S; Peiretti, F; Bonardo, B; Deprez-Beauclair, P; Laouenan, H; Juhan-Vague, I; Nalbone, G
      Effect of atorvastatin on plasminogen activator inhibitor type-1 synthesisin human monocytes/macrophages

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    77. Zager, RA; Johnson, A; Anderson, K; Wright, S
      Cholesterol ester accumulation: An immediate consequence of acute in vivo ischemic renal injury

      KIDNEY INTERNATIONAL
    78. Susekov, AV
      Validation of elevation of statins doses in clinical practice

      TERAPEVTICHESKII ARKHIV
    79. Jonsson, N; Asplund, K
      Does pretreatment with statins improve clinical outcome after stroke? A pilot case-referent study

      STROKE
    80. Larsen, J; Andersen, M; Kragstrup, J; Gram, LF
      Changes in the utilisation of lipid-lowering drugs over a 6-year period (1993-1998) in a Danish population

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    81. Isaacsohn, J; Zinny, M; Mazzu, A; Lettieri, J; Heller, AH
      Influence of gender on the pharmacokinetics, safety, and tolerability of cerivastatin in healthy adults

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    82. Gaist, D; Rodriguez, LAG; Huerta, C; Hallas, J; Sindrup, SH
      Are users of lipid-lowering drugs at increased risk of peripheral neuropathy?

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    83. DeBose-Boyd, RA; Ou, JF; Goldstein, JL; Brown, MS
      Expression of sterol regulatory element-binding protein 1c (SREBP-1c) mRNAin rat hepatoma cells requires endogenous LXR ligands

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    84. Cucchiara, B; Kasner, SE
      Use of statins in CNS disorders

      JOURNAL OF THE NEUROLOGICAL SCIENCES
    85. Joyce, M; Kelly, C; Winter, D; Chen, G; Leahy, A; Bouchier-Hayes, D
      Pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, attenuates renal injury in an experimental model of ischemia-reperfusion

      JOURNAL OF SURGICAL RESEARCH
    86. Dumont, AS; Hyndman, E; Dumont, RJ; Fedak, PM; Kassell, NF; Sutherland, GR; Verma, S
      Improvement of endothelial function in insulin-resistant carotid arteries treated with pravastatin

      JOURNAL OF NEUROSURGERY
    87. Chan, MHM; Mak, TWL; Chiu, RWK; Chow, CC; Chan, IHS; Lam, CWK
      Simvastatin increases serum osteocalcin concentration in patients treated for hypercholesterolaemia

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    88. Sandell, LJ; Silva, MJ
      What's new in orthopaedic research

      JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
    89. Satoh, K; Ichihara, K; Landon, EJ; Inagami, T; Tang, H
      3-hydroxy-3-methylglutaryl-CoA reductase inhibitors block calcium-dependent tyrosine kinase Pyk2 activation by angiotensin II in vascular endothelialcells - Involvement of geranylgeranylation of small G protein Rap1

      JOURNAL OF BIOLOGICAL CHEMISTRY
    90. Erl, W; Weber, KSC; Weber, PC; Weber, C
      Transient increase of monocyte adhesion after a single dose of simvastatin

      ATHEROSCLEROSIS
    91. Vasankari, T; Ahotupa, M; Toikka, J; Mikkola, J; Irjala, K; Pasanen, P; Neuvonen, K; Raitakari, O; Viikari, J
      Oxidized LDL and thickness of carotid intima-media are associated with coronary atherosclerosis in middle-aged men: lower levels of oxidized LDL withstatin therapy

      ATHEROSCLEROSIS
    92. Gonzalez-Fernandez, F; Jimenez, A; Lopez-Blaya, A; Velasco, S; Arriero, MM; Celdran, A; Rico, L; Farre, J; Casado, S; Lopez-Farre, A
      Cerivastatin prevents tumor necrosis factor-alpha-induced downregulation of endothelial nitric oxide synthase: role of endothelial cytosolic proteins

      ATHEROSCLEROSIS
    93. Rikitake, Y; Kawashima, S; Takeshita, S; Yamashita, T; Azumi, H; Yasuhara, N; Nishi, H; Inoue, N; Yokoyama, M
      Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits

      ATHEROSCLEROSIS
    94. Dupuis, J
      Mechanisms of acute coronary syndromes and the potential role of statins

      ATHEROSCLEROSIS
    95. Gnad, R; Kaina, B; Fritz, G
      Rho GTPases are involved in the regulation of NF-kappa B by genotoxic stress

      EXPERIMENTAL CELL RESEARCH
    96. Braunstein, JB; Cheng, A; Cohn, G; Aggarwal, M; Nass, CM; Blumenthal, RS
      Lipid disorders - Justification of methods and goals of treatment

      CHEST
    97. Branchi, A; Fiorenza, AM; Torri, A; Muzio, F; Rovellini, A; Berra, C; Sommariva, D
      Effects of atorvastatin 10 mg and simvastatin 20 mg on serum triglyceride levels in patients with hypercholesterolemia

      CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
    98. Ockene, IS; Matthews, CE; Rifai, N; Ridker, PM; Reed, G; Stanek, E
      Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults

      CLINICAL CHEMISTRY
    99. Mostaza, JM; De la Piedra, C; Curiel, MD; Pena, R; Lahoz, C
      Pravastatin therapy increases procollagen IN-terminal propeptide (PINP), amarker of bone formation in post-menopausal women

      CLINICA CHIMICA ACTA
    100. Dechend, R; Fiebeler, A; Park, JK; Muller, DN; Theuer, J; Mervaala, E; Bieringer, M; Gulba, D; Dietz, R; Luft, FC; Haller, H
      Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor

      CIRCULATION


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/06/20 alle ore 22:25:08